Ianalumab
Drug timelines are a Plus or Pro feature.
19 regulatory and trial events tracked for Ianalumab, covering 2025-01-27 to 2026-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome [Phase 3]